ClinicalTrials.Veeva

Menu

Analysis of the Persistence, Reservoir and HIV Latency (APRIL)

U

University Hospital, Strasbourg, France

Status

Not yet enrolling

Conditions

Informed Consent
HIV Infected Individuals

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The APRIL study aims at analyzing HIV reservoirs, latency and persistence on antiretroviral therapy. It enrolls HIV-infected adults providing blood samples of which peripheral blood mononuclear cells are stored. The frequency, phenotype and inducibility of HIV-infected cells are then analyzed. These parameters may vary across the different clinical and therapeutic settings.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV-infection
  • Adults (>18 years)
  • Social insurance
  • Informed consent

Exclusion criteria

  • HIV-uninfected
  • <18 years
  • Lack of social insurance
  • Lack or withdraw of consent

Trial contacts and locations

0

Loading...

Central trial contact

Pierre GANTNER, MCU-PH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems